Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc. filed an 8-K with the Securities and Exchange Commission on June 12, 2026, under the identifier linked to ticker SRNG — the original symbol of Soaring Eagle Acquisition Corp., the blank-check vehicle that took Ginkgo public through a de-SPAC transaction in 2021. Soaring Eagle was sponsored by Eagle Equity Partners, the vehicle of veteran media and entertainment investors Harry Sloan, Jeff Sagansky, and Eli Baker, and targeted the technology and life sciences sectors at IPO. Ginkgo Bioworks operates as a synthetic biology platform company, engineering organisms for applications across pharmaceuticals, agriculture, and industrial biotechnology. The June 2026 8-K represents a routine post-merger periodic disclosure for the operating company. Sign up for full data on SpacDesk to access Ginkgo's complete filing history, sponsor profile, and de-SPAC deal analytics.